$6.2 Million Wellcome Award for Non-Addictive Painkiller Research
Researchers in Nashville, Tennessee, and Glasgow, Scotland, received a Wellcome Trust Discover Award for research into a non-addictive painkiller.
Will Journavx, a New, Non-Addictive Painkiller, Eliminate Opioid Addiction?
The FDA has approved suzetrigine, a non-opiate signal blocker, for treatment of moderate and severe acute pain.
Facing Your Pain Is the Key to Happiness Says Addiction Expert
Anna Lembke, M.D., is the author of the book Dopamine Nation and co-author of a massive Stanford-Lancet report on the opioid crisis.